Our researchers are waging war on every cancer, no matter how many -- or how few -- are impacted.

Take progressive, metastatic medullary thyroid cancer: Only tens to a few hundred Americans were diagnosed with it in 2012. Yet MD Anderson has a team dedicated to this cancer, and its research has resulted in a new treatment that stalls tumor progression and even shrinks tumors in some patients.

"Rare cancers get intense...